LncRNA DANCR Promotes Sorafenib Resistance via Activation of IL-6/STAT3 Signaling in Hepatocellular Carcinoma Cells
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s229957
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2020
Authors
Publisher
Informa UK Limited